Urolithin A Revitalizes Aging Immune Cells in 28 Days

In a groundbreaking study published in Nature Aging, researchers have demonstrated the potential of urolithin A to rejuvenate immune cells in aging individuals. Specifically, the study revealed that a daily supplement of 1,000 mg of urolithin A could nudge aging immune cells toward a youthful profile over a short duration of 28 days.

Urolithin A: A Natural Compound with Promising Effects

Urolithin A is a metabolite derived from the gut bacteria that break down ellagic acid, which is found in various foods, including pomegranates and walnuts. When produced naturally, it occurs in much smaller amounts compared to those used in clinical supplements. Recent studies indicate that aging has adverse effects on immune function, characterized by:

• Reduced production of mature T cells
• Decreased naive T cell pools
• Chronic low-grade inflammation

At the core of these shifts lie mitochondrial dysfunction and waning autophagy, processes essential for maintaining cellular health.

Previous Findings and Stimulation of Mitophagy

Preclinical findings have identified urolithin A as a potent inducer of mitophagy, promoting the clearance of damaged mitochondria in both rodents and humans. Previous clinical trials have also demonstrated significant improvements in physical performance post-supplementation.

The following table summarizes key findings from the previous studies involving urolithin A:

Study Details and Methodology

The recent study titled “Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial” enrolled fifty participants aged between 45 and 70 years. The study design included:

• Randomization: Participants were split into two groups receiving either urolithin A or a placebo.
• Duration: The trial was conducted over a single period of 28 days.
• Objective: To assess phenotypic changes in peripheral CD3+ T cell subsets and immune metabolic remodeling.

Results of Urolithin A Supplementation

The findings from this study illustrate significant changes in immune cell composition:

• Expansion of CD8+ T cells with a more naive-like phenotype and reduced exhaustion markers.
• Statistical increase in PGC-1α, the master regulator of mitochondrial biogenesis.
• Enhanced fatty acid oxidation capacity by 14.72 percentage points.

These physiological changes indicate a shift towards improved mitochondrial health and a reduction in the inflammatory response typical of aging.

Conclusions and Future Directions

The authors conclude that short-term supplementation with urolithin A can potentially remodel immune cell composition and function, thereby counteracting age-related immune decline. The following implications arise from the study:

• The ability of urolithin A to enhance immune function through metabolic remodeling presents a promising avenue for addressing aging.
• Future studies should focus on the long-term impacts of urolithin A supplementation on human health.
• Understanding the complete mechanism of urolithin A’s action on immune function remains a critical area for additional research.

“Our findings suggest that urolithin A could help restore youthful immune profiles in aging adults, presenting opportunities for enhancing healthspan.” – Dr. Dominic Denk, Lead Researcher

References

[1] Denk, D., et al. (2025). Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature Aging.

[2] DOI: 10.1038/s43587-025-00996-x

[3] Urolithin A nudges aging immune cells toward a youthful profile in 28 days (2025, November 7) retrieved from https://medicalxpress.com/news/2025-11-urolithin-nudges-aging-immune-cells.html

In conclusion, the rejuvenating effects of urolithin A on aging immune cells are not just a remarkable finding but may pave the way for future therapeutics aimed at enhancing the health of the aging population.